AstraZeneca buys US biotech firm CinCor

The takeover marks the latest push by AstraZeneca chief executive Pascal Soriot to bolster the Covid vaccine maker's pipeline of new products.

Anglo-Swedish pharmaceuticals giant AstraZeneca on Monday agreed to buy US biotech company CinCor for $1.8 billion, expanding further into the field of heart and kidney drugs.

The takeover marks the latest push by Astra chief executive Pascal Soriot to bolster the COVID vaccine maker's pipeline of new products.

Massachusetts-based CinCor focuses on developing treatments for hypertension and chronic kidney disease.

Since taking the helm at AstraZeneca in 2012, Frenchman Soriot has expanded the company into lucrative cancer therapies.

The group completed a blockbuster takeover of Alexion for $39 billion in 2021, giving it more heft in areas such as treating blood disorders.

AstraZeneca buys US biotech firm CinCor

Taking a leave of absence can harm medical students' match prospects, finds study

In the nation's M.D.-Ph.D. programs, the socioeconomic gap widens

Police transport may influence restraint use in the emergency department

New tool can assess the climate of equity and inclusion in medical schools

Study: Why nurses are too often missing in health care leadership with major barriers to career advancement

The top Medical Xpress articles of 2023

Studying medicine, Nazism, and the Holocaust crucial to strengthening medical education and ethics, says new work

Wearable brain imaging provides a precise picture of children's developing brains

Researchers identify first step in allergic reactions, paving the way for preventative strategies

Facial thermal imaging and AI can accurately predict presence of coronary artery disease

Study: High excess death rates in the West for 3 years running since start of pandemic despite containment and vaccines

Inflight alcohol plus cabin pressure can lower blood oxygen and raise heart rate, even in the young and healthy

Personalized oxygenation could improve outcomes for patients on ventilators

Molecule produced in gut can have protective effect against flu, study shows

Genetic changes identified as key to childhood lupus

New method offers faster, more accurate pathogen identification, even in complex DNA sequences

Oral nucleoside antiviral is progressing toward future pandemic preparedness

New machine learning method can better predict spine surgery outcomes